Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-25 @ 2:45 PM
Study NCT ID:
NCT00073450
Status:
TERMINATED
Last Update Posted:
2015-04-21
First Post:
2003-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-09
Start Date Type:
None
Primary Completion Date:
2004-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-11-20
First Submit QC Date:
None
Study First Post Date:
2003-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-20
Last Update Post Date:
2015-04-21
Last Update Post Date Type:
ESTIMATED